States that expanded eligibility for Medicaid in 2014 and 2015 saw an immediate uptick in Medicaid prescriptions filled for diabetes treatments, suggesting the legislation played a direct role in improving access and adherence to those drugs.
Coronary microvascular dysfunction (CMD) identified with cardiac stress PET testing was a better predictor of adverse events among obese patients than body mass index (BMI) and other traditional risk factors, researchers reported in the Journal of the American College of Cardiology.
Swedish researchers have identified a potential mechanism for the endothelial dysfunction found in patients with type 2 diabetes (T2D): increased expression of the arginase I protein in red blood cells.
Continued use of statins was associated with a 25 percent reduced risk of major adverse cardiovascular events in patients after carotid revascularization, according to a Canadian study with five years of follow-up. But only about two-thirds of patients were taking moderate to high doses of the drugs prior to their procedures.
Moderately elevated levels of LDL cholesterol and systolic blood pressure (SBP) that persist for a long time are just as dangerous as very elevated values over a shorter timeframe, according to a new study published in PLOS One.
Lowering LDL cholesterol (LDL-C) beyond guideline-recommended levels further reduces cardiovascular events without compromising safety, according to a meta-analysis published Aug. 1 in JAMA Cardiology.
A simple measure of waist circumference could identify chronic heart failure patients who would benefit most from mineralocorticoid receptor antagonists, according to a review published July 25 in JAMA Cardiology.
A panel of experts believes genetic testing of individuals at risk of familial hypercholesterolemia (FH) could “alter the natural history” of the condition, which is estimated to be undiagnosed in more than 27 million people worldwide, including more than one million in the United States.
Higher body mass index (BMI) as a young adult may result in higher blood pressure (BP) and left ventricle mass index, resulting in changes to the heart structure, researchers report in the American Heart Association’s (AHA) journal Circulation.
Postmenopausal women with high levels of high-density lipoproteins (HDL) did not have the same cardioprotective benefits typically seen in women of other ages, researchers reported in the American Heart Association journal Arteriosclerosis, Thrombosis and Vascular Biology.
A recent review of almost 80 randomized control trials suggests increased intake of long-chain omega-3 (LCn3) polyunsaturated fatty acids from oily fish have minimal to no effect on mortality or cardiovascular health. Results of the review were published online July 18 in the Cochrane Library.
A team of researchers used genome editing to inactivate the PCSK9 protein in the livers of rhesus macaque monkeys, resulting in 30 to 60 percent reductions in LDL cholesterol and even more significant drops in PCSK9 levels.
On the heels of a deadlier-than-normal flu season, some scientists are wondering what will happen when a true pandemic hits. Vaccine doses would likely dry up—but cheap, readily available medications like statins could help a patient stave off flu as the virus runs its course, a pair of researchers told NPR.
School programs that provide fresh fruits and vegetables and limit the availability of sugar-sweetened beverages (SSBs) could prevent an estimated 22,383 deaths due to cardiometabolic disease each year in the U.S., researchers calculated in a study published July 6 in PLOS One.